Gene: Serpinb3a (serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A) Rattus norvegicus
Analyze
Symbol: Serpinb3a
Name: serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A
Description: Predicted to have protease binding activity and serine-type endopeptidase inhibitor activity; predicted to be involved in negative regulation of endopeptidase activity and protection from natural killer cell mediated cytotoxicity; predicted to localize to the extracellular space; orthologous to several human genes including SERPINB4 (serpin family B member 4); PARTICIPATES IN Entamoebiasis pathway; INTERACTS WITH bisphenol A; 2,3,7,8-tetrachlorodibenzodioxine (ortholog); 5-fluorouracil (ortholog).
Type: protein-coding
RefSeq Status: MODEL
Also known as: LOC498209; RGD1562868; serpin B4-like; similar to squamous cell carcinoma antigen 2
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.01327,153,500 - 27,159,319 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.01332,303,013 - 32,307,716 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41313,305,950 - 13,311,099 (-)NCBIRGSC3.4rn4RGSC3.4
Celera1323,086,931 - 23,092,755 (-)NCBICelera
Cytogenetic Map13p11NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations
Gene-Chemical Interaction Annotations
Gene Ontology Annotations
Molecular Pathway Annotations
References - curated
References - uncurated

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)
Damaging Variants

Additional Information

External Database Links
Nomenclature History
 
More on Serpinb3a
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

CRRD Object Information
CRRD ID: 1562868
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-04-23
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.